跳至主要内容
临床试验/NL-OMON31901
NL-OMON31901招募中不适用

PRedicting Outcome using systemic Markers In Severe Exacerbations of COPD - The PROMISE-COPD Cohort Study - Systemic makers in severe exacerbations of COPD

Medisch Centrum Alkmaar0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age above 40 years;
  • Smoking history >= 10 pack years;
  • Moderate to very severe COPD (GOLD II to IV);
  • Currently stable disease (at least 4 weeks after resolution of the last exacerbation);
  • Willingness to participate in a longitudinal, cohort study;
  • Willingness of the family physician to have the patient included in a cohort study;
  • Written informed consent.

排除标准

  • Rapid fatal disease;
  • Pulmonary condition other than COPD as the main respiratory disease, e.g. bronchiectasis, asthma or pulmonary fibrosis;
  • Immunosuppression including HIV, organ transplantation or chronic steroid use (more than 10mg prednisolone-equivalent per day);
  • Patients unable and unwilling to give written informed consent;
  • Muskulo-skeletal process preventing ambulation.

研究者

发起方
Medisch Centrum Alkmaar

相似试验